Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uveitis associated with multiple sclerosis.

Julie Le Scanff1, Pascal Sève, Christel Renoux

  • 1Department of Internal Medicine, Hospices Civils de Lyon, Hotel Dieu, 1 place de l'Hôpital, 69288 Lyon Cedex 02, France.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|January 23, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct Oral Anticoagulants, COX-2-Selective NSAIDs, and Gastrointestinal Bleeding in Atrial Fibrillation.

JAMA network open·2026
Same author

Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study.

British journal of clinical pharmacology·2025
Same author

Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with non-valvular atrial fibrillation: a multinational cohort study.

BMC medicine·2025
Same author

Incretin-Based Drugs and the Risk of Dementia Among Patients with Type 2 Diabetes.

Drug safety·2025
Same author

Trends in first-line monotherapy and combination therapy for hypertension in UK primary care.

British journal of clinical pharmacology·2025
Same author

Effectiveness and safety of rivaroxaban vs. apixaban in patients with atrial fibrillation and peripheral artery disease.

European heart journal. Cardiovascular pharmacotherapy·2025
Same journal

Association of epiretinal membranes with disability in people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Epiretinal membranes in multiple sclerosis: A window into glial pathobiology?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

This study found that uveitis occurs in 0.65% of multiple sclerosis (MS) patients. Uveitis timing relative to MS onset did not impact the disease

Area of Science:

  • Ophthalmology
  • Neurology
  • Immunology

Background:

  • Uveitis is an ocular inflammatory condition.
  • Multiple sclerosis (MS) is a chronic neurological disease.
  • The relationship between uveitis and MS requires further investigation.

Purpose of the Study:

  • To determine the prevalence of uveitis in multiple sclerosis patients.
  • To compare the clinical spectrum and time course of MS in patients with or without uveitis.

Main Methods:

  • Retrospective analysis of the Lyon MS Database.
  • Identification of patients diagnosed with uveitis.
  • Comparison of MS clinical course and prognosis between groups.

Main Results:

Related Experiment Videos

  • Prevalence of uveitis in the MS cohort was 0.65% (28/4,300).
  • Uveitis preceded MS onset in 46% of cases, occurred simultaneously in 18%, and followed in 36%.
  • No significant differences in MS course or prognosis were observed based on uveitis presence or timing.

Conclusions:

  • Uveitis is relatively uncommon in MS patients.
  • The timing of uveitis in relation to MS does not appear to affect MS prognosis.
  • Ocular inflammation in MS patients does not alter the neurological disease course.